Pulmonary hypertension other diagnostic studies

Jump to navigation Jump to search

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension other diagnostic studies

CDC on Pulmonary hypertension other diagnostic studies

Pulmonary hypertension other diagnostic studies in the news

Blogs on Pulmonary hypertension other diagnostic studies

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Assistant Editor(s)-in-Chief: Ralph Matar; Rim Halaby

Overview

Pulmonary hypertension diagnosis is made using right heart cardiac catheterization. It is mandatory for diagnosing pulmonary arterial hypertension. It confirms the diagnosis and evaluates for some causes such as valvular heart diseases. Other studies may also be performed. These studies include pulmonary function tests, overnight oximetry, and ventilation-perfusion studies (which is crucial to rule out chronic pulmonary thromboembolism).

Key Findings in Right Heart Catheterization in Pulmonary Hypertension

  • Right heart catheterization allows the determination of:[1][2][3][4][5][6]
  • Fick’s method is reliable in patients with PAH for the measurement of cardiac output:
    • Cardiac Output = oxygen consumption/arteriovenous oxygen difference x 100
  • Since end-expiratory intrathoracic pressure most closely correlates with atmospheric pressure, it is important that all right ventricular, pulmonary artery, pulmonary wedge, and left ventricular pressures be measured at end-expiration.


Other Diagnostic Studies

  • The other diagnostic studies are as follows:[7][8]
    • Pulmonary function tests
      • The aim of pulmonary function tests is to detect any obstructive or restrictive patten of an underlying lung disease that might be causing the pulmonary hypertension.
    • Overnight oximetry
      • Overnights oximetry might be used in some patients with pulmonary hypertension in order to assess the necessity of oxygen therapy during sleep time.
    • Ventilation-perfusion studies
      • Ventilation-perfusion studies are done to rule out any thromboembolic diseases in the lungs.[9]

References

  1. Rosenkranz S, Preston IR (December 2015). "Right heart catheterisation: best practice and pitfalls in pulmonary hypertension". Eur Respir Rev. 24 (138): 642–52. doi:10.1183/16000617.0062-2015. PMID 26621978.
  2. Guo X, Liu M, Ma Z, Wang S, Yang Y, Zhai Z, Wang C, Zhai R (2014). "Flow characteristics of the proximal pulmonary arteries and vena cava in patients with chronic thromboembolic pulmonary hypertension: correlation between 3.0 T phase-contrast MRI and right heart catheterization". Diagn Interv Radiol. 20 (5): 414–20. doi:10.5152/dir.2014.13501. PMC 4463330. PMID 25163757.
  3. Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D (August 2014). "Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population". J Am Heart Assoc. 3 (4). doi:10.1161/JAHA.114.001103. PMC 4310406. PMID 25146706.
  4. D'Alto M, Romeo E, Argiento P, D'Andrea A, Vanderpool R, Correra A, Bossone E, Sarubbi B, Calabrò R, Russo MG, Naeije R (October 2013). "Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension". Int. J. Cardiol. 168 (4): 4058–62. doi:10.1016/j.ijcard.2013.07.005. PMID 23890907.
  5. Hoeper MM, Lee SH, Voswinckel R, Palazzini M, Jais X, Marinelli A, Barst RJ, Ghofrani HA, Jing ZC, Opitz C, Seyfarth HJ, Halank M, McLaughlin V, Oudiz RJ, Ewert R, Wilkens H, Kluge S, Bremer HC, Baroke E, Rubin LJ (December 2006). "Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers". J. Am. Coll. Cardiol. 48 (12): 2546–52. doi:10.1016/j.jacc.2006.07.061. PMID 17174196.
  6. Taylor B, Rumbak M, Taylor SP, Solomon D (January 2013). "Early versus delayed right heart catheterization in evaluation of pulmonary arterial hypertension". J. Heart Lung Transplant. 32 (1): 137–8. doi:10.1016/j.healun.2012.10.004. PMID 23260714.
  7. Presberg KW, Dincer HE (2003). "Pathophysiology of pulmonary hypertension due to lung disease". Curr Opin Pulm Med. 9 (2): 131–8. PMID 12574693.
  8. Minai OA, Pandya CM, Golish JA, Avecillas JF, McCarthy K, Marlow S; et al. (2007). "Predictors of nocturnal oxygen desaturation in pulmonary arterial hypertension". Chest. 131 (1): 109–17. doi:10.1378/chest.06-1378. PMID 17218563.
  9. Poch D, Mandel J (2021). "Pulmonary Hypertension". Ann Intern Med. 174 (4): ITC49–ITC64. doi:10.7326/AITC202104200. PMID 33844574 Check |pmid= value (help).